Blue Jay Capital Management as of Sept. 30, 2016
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 17 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 7.0 | $13M | 41k | 313.03 | |
| BioMarin Pharmaceutical (BMRN) | 7.0 | $13M | 138k | 92.52 | |
| Incyte Corporation (INCY) | 6.6 | $12M | 128k | 94.29 | |
| Clovis Oncology | 6.6 | $12M | 335k | 36.05 | |
| Tesaro | 6.6 | $12M | 120k | 100.24 | |
| Wright Medical Group Nv | 6.5 | $12M | 486k | 24.53 | |
| Hologic (HOLX) | 6.5 | $12M | 306k | 38.83 | |
| Ironwood Pharmaceuticals (IRWD) | 6.3 | $12M | 725k | 15.88 | |
| Neurocrine Biosciences (NBIX) | 6.3 | $12M | 227k | 50.64 | |
| Illumina (ILMN) | 5.9 | $11M | 59k | 181.66 | |
| Smith & Nephew (SNN) | 5.8 | $11M | 325k | 32.78 | |
| Masimo Corporation (MASI) | 5.4 | $9.9M | 166k | 59.49 | |
| Dermira | 5.1 | $9.3M | 275k | 33.82 | |
| Perrigo Company (PRGO) | 5.0 | $9.2M | 100k | 92.33 | |
| NuVasive | 4.7 | $8.6M | 130k | 66.66 | |
| Qiagen | 4.5 | $8.2M | 300k | 27.44 | |
| Allscripts Healthcare Solutions (MDRX) | 4.3 | $7.9M | 600k | 13.17 |
